Jonathan Mitry Hyak (Jonathan M Hyak, Jonathan Hyak)

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 9

Top Topics

Chronic Lymphocytic Leukemia

Hodgkin Lymphoma

Top Venues

Infection control and hospital epidemiology

Hematological oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Paul Joseph Hampel, Mahesh Swaminathan, Kerry A Rogers, Erin M Parry, Jan A Burger, Matthew S Davids, Wei Ding, Alessandra Ferrajoli, Jonathan Mitry Hyak, Nitin Jain, Saad S Kenderian, Yucai Wang, William G Wierda, Jennifer A Woyach, Sameer A Parikh, Phillip A Thompson
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia. Blood advances 8 (10) (2024)
Paul Joseph Hampel, Mahesh Swaminathan, Kerry A Rogers, Erin M Parry, Jan A Burger, Matthew S Davids, Wei Ding, Alessandra Ferrajoli, Jonathan Mitry Hyak, Nitin Jain, Saad S Kenderian, Yucai Wang, William G Wierda, Jennifer A Woyach, Sameer A Parikh, Phillip A Thompson
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia. Blood advances 8 (10) (2024)
Paul Joseph Hampel, Mahesh Swaminathan, Kerry A Rogers, Erin M Parry, Jan A Burger, Matthew S Davids, Wei Ding, Alessandra Ferrajoli, Jonathan Mitry Hyak, Nitin Jain, Saad S Kenderian, Yucai Wang, William G Wierda, Jennifer A Woyach, Sameer A Parikh, Phillip A Thompson
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia. Blood advances (2024)
Paul Joseph Hampel, Mahesh Swaminathan, Kerry A Rogers, Erin M Parry, Jan A Burger, Matthew S Davids, Wei Ding, Alessandra Ferrajoli, Jonathan Mitry Hyak, Nitin Jain, Saad S Kenderian, Yucai Wang, William G Wierda, Jennifer A Woyach, Sameer A Parikh, Phillip A Thompson
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia. Blood advances 8 (10) (2024)
Paul Joseph Hampel, Mahesh Swaminathan, Kerry A Rogers, Erin M Parry, Jan A Burger, Matthew S Davids, Wei Ding, Alessandra Ferrajoli, Jonathan Mitry Hyak, Nitin Jain, Saad S Kenderian, Yucai Wang, William G Wierda, Jennifer A Woyach, Sameer A Parikh, Phillip A Thompson
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia. Blood advances 8 (10) (2024)
Paul Joseph Hampel, Mahesh Swaminathan, Kerry A Rogers, Erin M Parry, Jan A Burger, Matthew S Davids, Wei Ding, Alessandra Ferrajoli, Jonathan Mitry Hyak, Nitin Jain, Saad S Kenderian, Yucai Wang, William G Wierda, Jennifer A Woyach, Sameer A Parikh, Phillip A Thompson
A multicenter study of venetoclax-based treatment for patients with Richter transformation of chronic lymphocytic leukemia. Blood advances 8 (10) (2024)
Matthew R Avenarius, Ying Huang, Jonathan Mitry Hyak, John C Byrd, Seema A Bhat, Michael Grever, Adam S Kittai, Kerry A Rogers, Daniel M Jones, Weiqiang Zhao, Nyla A Heerema, Lynne V Abruzzo, Jennifer Woyach, Cecelia R Miller
Refining prognosis in chronic lymphocytic leukemia with normal Fluorescence in situ hybridization results. Hematological oncology (2023)
Jonathan Mitry Hyak, Ying Huang, Kerry A Rogers, Seema A Bhat, Michael R Grever, John C Byrd, Adam S Kittai, Daniel M Jones, Cecelia R Miller, Jennifer A Woyach
Combined BCL2 and BTK inhibition in CLL demonstrates efficacy after monotherapy with both classes. Blood advances 6 (17) (2022)
Jonathan Mitry Hyak, Mayar Al Mohajer, Daniel M Musher, Benjamin L Musher
Clinical prediction of bacteremia and early antibiotics therapy in patients with solid tumors. Infection control and hospital epidemiology (2021)